SCHEMBL1774608

SCHEMBL1774608

CN1CCN(c2nccc3sc(S(=O)(=O)Nc4cccc(Cl)c4)cc23)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 10/20 0.51
HTR1A P08908 4/20 0.51
HTR2A P28223 4/20 0.51
HTR1D P28221 3/20 0.51
HTR1B P28222 3/20 0.51
HTR7 P34969 3/20 0.51
DRD2 P14416 4/20 0.45
HTR2C P28335 2/20 0.45
DRD3 P35462 2/20 0.45
HTR1E P28566 1/20 0.45
HTR1F P30939 1/20 0.45
ADRA1B P35368 1/20 0.45
HTR2B P41595 1/20 0.45
HTR4 Q13639 1/20 0.45
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1775137 0.99 HTR6 (0.50) HTR6HTR1AHTR2AHTR1DHTR1B
SCHEMBL1775401 0.89 HRH4 (0.45) HTR6HTR1AHTR2AHTR1DHTR1B
Hydrochloric Acid SCHEMBL1774702 0.88 HRH4 (0.44) HTR6HTR1AHTR2AHTR1DHTR1B
SCHEMBL1775535 0.85 FLT3 (0.46) HTR6HTR1AHTR2AHTR1DHTR1B
Hydrochloric Acid SCHEMBL1773881 0.84 FLT3 (0.45) HTR6HTR1AHTR2AHTR1DHTR1B
SCHEMBL1775441 0.84 HTR6 (0.45) HTR6HTR1AHTR2AHTR1DHTR1B
Hydrochloric Acid SCHEMBL1775491 0.83 HTR6 (0.45) HTR6HTR1AHTR2AHTR1DHTR1B
SCHEMBL5015937 0.79 HRH4 (0.46) HTR1AHTR2AHTR1DHTR1BDRD2
SCHEMBL1777009 0.78 MALT1 (0.48) HTR6HTR1AHTR2AHTR1DHTR1B
SCHEMBL1774831 0.77 HTR6 (0.50) HTR6HTR1AHTR2AHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943639-B2 Such as 6-benzenesulfonyl-4-piperazin-1-yl-quinoline hydrochloride; for treatment of central nervous system and/or 5- HT6 receptor related disorders; for weight gain/loss PROXIMAGEN LIMITED (GB) 2011-05-17 US claimed